Pierre Fabre Pharma GmbH
6 clinical trials · Sponsor
◉ Watch Pierre Fabre Pharma GmbH
| Record | Firm | Date |
|---|---|---|
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment (NCT04673955) | Pierre Fabre Pharma GmbH | 2020-09-03 |
| Real-life Pan-HER-blockade With Neratinib (NCT04388384) | Pierre Fabre Pharma GmbH | 2020-07-02 |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment (NCT04045691) | Pierre Fabre Pharma GmbH | 2019-10-17 |
Track Pierre Fabre Pharma GmbH automatically
Every clearance here is in the API, with alerts when new ones post.